Validation of a multicellular tumor microenvironment system for modeling patient tumor biology and drug response
Abstract Lung cancer rates are rising globally and non-small cell lung cancer (NSCLC) has a five year survival rate of only 24%. Unfortunately, the development of drugs to treat cancer is severely hampered by the inefficiency of translating pre-clinical studies into clinical benefit. Thus, we sought...
Guardado en:
Autores principales: | Devin G. Roller, Stephen A. Hoang, Kristopher D. Rawls, Katherine A. Owen, Michael B. Simmers, Robert A. Figler, Julia D. Wulfkuhle, Emanuel F. Petricoin, Brian R. Wamhoff, Daniel Gioeli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c42edff85c244b88abc08fd238c4aa8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening
por: Millard M, et al.
Publicado: (2017) -
Recent Advances in Multicellular Tumor Spheroid Generation for Drug Screening
por: Kwang-Ho Lee, et al.
Publicado: (2021) -
Tumor microenvironment: the formation of the immune profile
por: E. K. Oleinik, et al.
Publicado: (2020) -
Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Changjing Huang, et al.
Publicado: (2021) -
Coaxial 3D bioprinting of self-assembled multicellular heterogeneous tumor fibers
por: Xingliang Dai, et al.
Publicado: (2017)